Fuchs Henry J
CIK 0001197355
President, Worldwide R&DDirector
Filings
13
Latest Sep 17, 2024
Issuers covered
2
Showing
13 of 13
Page 1
Track record
2 of 5 open-market trades scored (40% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -0.5% | -0.5% | +0.1% | -1.0% |
| 90 days | 2 | 100% | +8.6% | +8.6% | +11.2% | +5.9% |
| 180 days | 2 | 50% | -2.6% | -2.6% | +1.2% | -6.5% |
| 365 days | 2 | 100% | +9.9% | +9.9% | +17.2% | +2.5% |
Issuers
Companies where Fuchs Henry J has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 10 | Sep 17, 2024 |
| MRTX | Mirati Therapeutics, Inc. | 3 | Jan 24, 2023 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|